STOCK TITAN

Johnson & Johnson (JNJ) legal chief sells 15,918 shares after option exercise

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Johnson & Johnson executive Elizabeth Forminard, EVP and Chief Legal Officer, exercised employee stock options covering 9,344 shares of common stock on August 6, 2026. These options, granted under the company’s Long-Term Incentive Plan, had an exercise price of $131.94 per share and an expiration date of February 11, 2029.

On the same date, she acquired 9,344 shares of common stock through the option exercise and then sold a total of 15,918 shares of common stock in open market or private transactions, including 9,344 shares at $257.755 per share and 6,574 shares at $255.932 per share. After the exercise, the reported balance for this specific stock option award was 0 shares.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Forminard Elizabeth
Role EVP, Chief Legal Officer
Sold 15,918 shs ($4.09M)
Approx. gross sale proceeds $4.09M
Approx. exercise cost $1.23M
Type Security Shares Price Value
Exercise Employee Stock Options (Right to Buy) F1 9,344 $0.00 $0.00
Exercise Common Stock 9,344 $131.94 $1.23M
Sale Common Stock 9,344 $257.755 $2.41M
Sale Common Stock 6,574 $255.932 $1.68M
Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 shares (Direct); Common Stock — 16,994 shares (Direct)
Footnotes (1)
  1. F1. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Options Exercised 9,344 shares Employee stock options exercised by EVP Elizabeth Forminard on August 6, 2026
Exercise Price $131.94 per share Exercise price of employee stock options granted under Long-Term Incentive Plan
Option Expiration February 11, 2029 Expiration date of the employee stock option award exercised
Shares Sold 15,918 shares Total Johnson & Johnson common shares sold in reported transactions on August 6, 2026
Sale Price for 9,344 Shares $257.755 per share Per-share price for sale of 9,344 Johnson & Johnson common shares
Sale Price for 6,574 Shares $255.932 per share Per-share price for sale of 6,574 Johnson & Johnson common shares
Employee Stock Options (Right to Buy) financial
"Security title is Employee Stock Options (Right to Buy) for 9,344 shares."
Long-Term Incentive Plan financial
"Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable..."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open market or private transaction financial
"Sale in open market or private transaction is the description for the S-coded sales."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Johnson & Johnson (JNJ) EVP Elizabeth Forminard report in this Form 4?

Elizabeth Forminard reported exercising 9,344 employee stock options at $131.94 per share and then selling 15,918 Johnson & Johnson common shares in market transactions at prices of $257.755 and $255.932 per share.

How many Johnson & Johnson (JNJ) shares did Elizabeth Forminard sell?

Elizabeth Forminard sold 15,918 shares of Johnson & Johnson common stock on August 6, 2026. The reported sales consisted of 9,344 shares at $257.755 per share and 6,574 shares at $255.932 per share in open market or private transactions.

What stock options did Elizabeth Forminard exercise at Johnson & Johnson (JNJ)?

She exercised employee stock options for 9,344 shares of Johnson & Johnson common stock at an exercise price of $131.94 per share. The options were granted under the Long-Term Incentive Plan and carry an expiration date of February 11, 2029.

Were Elizabeth Forminard’s Johnson & Johnson (JNJ) option awards part of a long-term incentive plan?

Yes. A footnote states the employee stock option award was granted under Johnson & Johnson’s Long-Term Incentive Plan and that the award vests and becomes exercisable on the third anniversary of the grant date associated with the option.

What is the expiration date of the exercised Johnson & Johnson (JNJ) stock options?

The exercised options have an expiration date of February 11, 2029. They relate to an employee stock option award granted under Johnson & Johnson’s Long-Term Incentive Plan and were exercised for 9,344 shares of common stock at $131.94 per share.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Forminard Elizabeth

(Last)(First)(Middle)
ONE JOHNSON & JOHNSON PLAZA

(Street)
NEW BRUNSWICK NEW JERSEY 08933

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/06/2026M9,344A$131.9432,912D
Common Stock08/06/2026S9,344D$257.75523,568D
Common Stock08/06/2026S6,574D$255.93216,994D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options (Right to Buy)$131.9408/06/2026M9,34402/11/2022(1)02/11/2029Common Stock9,344$00D
Explanation of Responses:
1. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Remarks:
/s/ Joleen Morgan, as attorney-in-fact for Elizabeth Forminard08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)